Profilo
Anna Gralinska is currently the Head of Corporate Communications at Bio-Rad Laboratories, Inc. She previously worked as the Director of Investor Relations at Mallinckrodt Hospital Products, Inc.
Posizioni attive di Anna Gralinska
| Società | Posizione | Inizio |
|---|---|---|
| BIO-RAD LABORATORIES, INC. | Public Communications Contact | 01/04/2022 |
Precedenti posizioni note di Anna Gralinska
| Società | Posizione | Fine |
|---|---|---|
| CADENCE PHARMACEUTICALS, INC. | Contatto Relazioni con gli Investitori | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BIO-RAD LABORATORIES, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Mallinckrodt Hospital Products, Inc.
 Mallinckrodt Hospital Products, Inc. Pharmaceuticals: MajorHealth Technology Mallinckrodt Hospital Products, Inc. operates as a biopharmaceutical company, which develops and commercializes proprietary product candidates used in the hospital setting. The firm offers OFIRMEV (acetaminophen injection), a proprietary intravenous formulation of acetaminophen for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics and the reduction of fever. The company was founded by Theodore R. Schroeder, David A. Socks, and Cam L. Garner on May 26, 2004 and is headquartered in Hazelwood, MO. | Health Technology |
- Borsa valori
- Insiders
- Anna Gralinska
